MHC II antagonists (Debiopharm)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMHC II antagonists (Debiopharm)
Drug Alias NameDebio-0406HLA Class II Antigen Inhibitor (GPC Biotech AG/Debiopharm SA)autoimmune disease therapy (GPC Biotech/Debiopharm)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistocompatibility antigens class II inhibitors
TargetsHistocompatibility antigens class II
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGpc Biotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDebiopharm International Sa
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A